128 related articles for article (PubMed ID: 21868542)
1. Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis.
Mohr SB; Gorham ED; Alcaraz JE; Kane CJ; Macera CA; Parsons JK; Wingard DL; Garland CF
Anticancer Res; 2011 Sep; 31(9):2939-48. PubMed ID: 21868542
[TBL] [Abstract][Full Text] [Related]
2. Dose-response of serum 25-hydroxyvitamin D in association with risk of colorectal cancer: A meta-analysis.
Garland CF; Gorham ED
J Steroid Biochem Mol Biol; 2017 Apr; 168():1-8. PubMed ID: 27993551
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: serum vitamin D and breast cancer risk.
Yin L; Grandi N; Raum E; Haug U; Arndt V; Brenner H
Eur J Cancer; 2010 Aug; 46(12):2196-205. PubMed ID: 20456946
[TBL] [Abstract][Full Text] [Related]
5. Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies.
Chen P; Li M; Gu X; Liu Y; Li X; Li C; Wang Y; Xie D; Wang F; Yu C; Li J; Chen X; Chu R; Zhu J; Ou Z; Wang H
PLoS One; 2013; 8(1):e49312. PubMed ID: 23382798
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis.
Kim Y; Je Y
Br J Cancer; 2014 May; 110(11):2772-84. PubMed ID: 24714744
[TBL] [Abstract][Full Text] [Related]
7. Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies.
Wang D; Vélez de-la-Paz OI; Zhai JX; Liu DW
Tumour Biol; 2013 Dec; 34(6):3509-17. PubMed ID: 23807676
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D and prevention of breast cancer: pooled analysis.
Garland CF; Gorham ED; Mohr SB; Grant WB; Giovannucci EL; Lipkin M; Newmark H; Holick MF; Garland FC
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):708-11. PubMed ID: 17368188
[TBL] [Abstract][Full Text] [Related]
9. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study.
Bilinski K; Boyages J
Breast Cancer Res Treat; 2013 Jan; 137(2):599-607. PubMed ID: 23239153
[TBL] [Abstract][Full Text] [Related]
10. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.
Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
Carcinogenesis; 2008 Jan; 29(1):93-9. PubMed ID: 17974532
[TBL] [Abstract][Full Text] [Related]
11. Serum 25-hydroxyvitamin D and breast cancer in the military: a case-control study utilizing pre-diagnostic serum.
Mohr SB; Gorham ED; Alcaraz JE; Kane CI; Macera CA; Parsons JK; Wingard DL; Horst R; Garland CF
Cancer Causes Control; 2013 Mar; 24(3):495-504. PubMed ID: 23296455
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D Status and Risk of Breast Cancer in Iranian Women: A Case-Control Study.
Jamshidinaeini Y; Akbari ME; Abdollahi M; Ajami M; Davoodi SH
J Am Coll Nutr; 2016; 35(7):639-646. PubMed ID: 27331363
[TBL] [Abstract][Full Text] [Related]
13. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women.
Fedirko V; Torres-Mejía G; Ortega-Olvera C; Biessy C; Angeles-Llerenas A; Lazcano-Ponce E; Saldaña-Quiroz VA; Romieu I
Cancer Causes Control; 2012 Jul; 23(7):1149-62. PubMed ID: 22622862
[TBL] [Abstract][Full Text] [Related]
14. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies.
Maalmi H; Ordóñez-Mena JM; Schöttker B; Brenner H
Eur J Cancer; 2014 May; 50(8):1510-21. PubMed ID: 24582912
[TBL] [Abstract][Full Text] [Related]
15. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status.
Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1339-43. PubMed ID: 18559548
[TBL] [Abstract][Full Text] [Related]
16. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.
Bertone-Johnson ER; Chen WY; Holick MF; Hollis BW; Colditz GA; Willett WC; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1991-7. PubMed ID: 16103450
[TBL] [Abstract][Full Text] [Related]
17. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years.
Eliassen AH; Warner ET; Rosner B; Collins LC; Beck AH; Quintana LM; Tamimi RM; Hankinson SE
Cancer Res; 2016 Sep; 76(18):5423-30. PubMed ID: 27530324
[TBL] [Abstract][Full Text] [Related]
18. 25-hydroxyvitamin D and breast cancer, colorectal cancer, and colorectal adenomas: case-control versus nested case-control studies.
Grant WB
Anticancer Res; 2015 Feb; 35(2):1153-60. PubMed ID: 25667506
[TBL] [Abstract][Full Text] [Related]
19. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer.
Mohr SB; Gorham ED; Kim J; Hofflich H; Garland CF
Anticancer Res; 2014 Mar; 34(3):1163-6. PubMed ID: 24596354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
